Transport and intracellular distribution of MHC class II molecules and associated invariant chain in normal and antigen-processing mutant cell lines

We have compared the intracellular transport and subcellular distribution of MHC class II-invariant chain complexes in a wild-type HLA-DR3 homozygous cell line and a mutant cell line, T2.DR3. The latter has a defect in antigen processing and accumulates HLA-DR3 molecules associated with an invariant chain-derived peptide (CLIP) rather than the normal complement of peptides derived from endocytosed proteins. We find that in the wild-type cells, CLIP is transiently associated with HLA-DR3 molecules, suggesting that the peptide is a normal class II- associated intermediate generated during proteolysis of the invariant chain. In the mutant cell line proteolysis of the invariant chain is less efficient, and HLA-DR3/CLIP complexes are generated much more slowly. Examination of the mutant cell line by immunoelectronmicroscopy shows that class II-invariant chain complexes accumulate intracellularly in large acidic vesicles which contain lysosomal markers, including beta-hexosaminidase, cathepsin D, and the lysosomal membrane protein CD63. The markers in these vesicles are identical to those seen in the class II-containing vesicles (MIICs) seen in the wild- type cells but the morphology is drastically different. The vesicles in the mutant cells are endocytic, as measured by the internalization of BSA-gold conjugates. The implication of these findings for antigen processing in general and the nature of the mutation in particular are discussed.

[1]  H. Geuze,et al.  Immunogenic peptides bind to class II MHC molecules in an early lysosomal compartment. , 1993, Journal of immunology.

[2]  J. Yewdell,et al.  Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments , 1993, The Journal of experimental medicine.

[3]  P. Cresswell,et al.  Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. , 1993, Journal of immunology.

[4]  S. Ceman,et al.  Invariant chain peptides in most HLA-DR molecules of an antigen-processing mutant. , 1992, Science.

[5]  P. Cresswell,et al.  HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.

[6]  William S. Lane,et al.  Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.

[7]  Eric O Long,et al.  Stable surface expression of invariant chain prevents peptide presentation by HLA‐DR. , 1992, The EMBO journal.

[8]  A Sette,et al.  Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.

[9]  P. Cresswell,et al.  Assembly and transport properties of invariant chain trimers and HLA-DR-invariant chain complexes. , 1992, Journal of immunology.

[10]  P. Cresswell,et al.  The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation. , 1992, Journal of immunology.

[11]  J. Neefjes,et al.  Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes. , 1992, The EMBO journal.

[12]  P. Cresswell,et al.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain , 1991, Nature.

[13]  R. Germain,et al.  MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.

[14]  J. Yewdell,et al.  Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Peter J. Peters Cytotoxic T lymphocyte granules are secretory lysosomes, containing both perforin and granzymes , 1991, The Journal of experimental medicine.

[16]  P. Cresswell,et al.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Slot,et al.  Immuno-localization of the insulin regulatable glucose transporter in brown adipose tissue of the rat , 1991, The Journal of cell biology.

[18]  H. Geuze,et al.  Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.

[19]  M J Metzelaar,et al.  CD63 antigen. A novel lysosomal membrane glycoprotein, cloned by a screening procedure for intracellular antigens in eukaryotic cells. , 1991, The Journal of biological chemistry.

[20]  E. Unanue,et al.  Liposome-encapsulated antigens are processed in lysosomes, recycled, and presented to T cells , 1991, Cell.

[21]  P. A. Peterson,et al.  Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.

[22]  O. Bakke,et al.  MHC class II-associated invariant chain contains a sorting signal for endosomal compartments , 1990, Cell.

[23]  P. Cresswell,et al.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.

[24]  B. Arp,et al.  Defective processing and presentation of exogenous antigens in mutants with normal HLA class II genes , 1990, Nature.

[25]  W. Knapp,et al.  Inhibition by leupeptin and antipain of the intracellular proteolysis of Ii. , 1989, Human immunology.

[26]  J. Slot,et al.  Sorting of mannose 6-phosphate receptors and lysosomal membrane proteins in endocytic vesicles , 1988, The Journal of cell biology.

[27]  P. Cresswell,et al.  Role for intracellular proteases in the processing and transport of class II HLA antigens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Schägger,et al.  Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. , 1987, Analytical biochemistry.

[29]  V. Quaranta,et al.  Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells , 1985, The Journal of experimental medicine.

[30]  J. Slot,et al.  A new method of preparing gold probes for multiple-labeling cytochemistry. , 1985, European journal of cell biology.

[31]  M. Brown,et al.  Visualization of acidic organelles in intact cells by electron microscopy. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Cresswell,et al.  Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens. , 1982, Journal of immunology.

[33]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[34]  P. Peters,et al.  A new model for lethal hit delivery by cytotoxic T lymphocytes. , 1990, Immunology today.

[35]  A. Townsend,et al.  Antigen recognition by class I-restricted T lymphocytes. , 1989, Annual review of immunology.

[36]  P. Cresswell,et al.  4 – Intracellular Transport of Class II HLA Antigens , 1988 .

[37]  E. Unanue Antigen-presenting function of the macrophage. , 1984, Annual review of immunology.